Estradiol Recruiting Phase 2 Trials for Cardiovascular Risk Reduction Prevention

IndicationsStatusPurposePhase
RecruitingPrevention2
clinicaltrials.gov IdentifierTitleDrugs
NCT03815929Oophorectomy, Estrogen Therapy and Cardiovascular Disease Risk in Young Women